Isomorphic Labs

Alphabet spinout applying AI to revolutionize drug discovery and molecular design

London, United Kingdom Founded 2021 201-500 employees Research

About Isomorphic Labs

Isomorphic Labs is a digital biology and AI drug discovery company applying artificial intelligence to the challenge of developing new medicines. The company works at the intersection of computational science, biology and pharmaceutical research to improve how researchers understand disease and identify potential therapeutic molecules. Its approach uses advanced AI models and computational methods to represent biological systems and support the discovery of drug candidates. Isomorphic Labs collaborates with pharmaceutical partners and scientific teams, combining machine learning with experimental research to investigate targets and accelerate stages of the drug discovery process. Isomorphic Labs is relevant to AI drug discovery, computational biology, digital biology, machine learning in pharmaceutical research and next-generation medicine development. Its work aims to make drug research more predictive and efficient, while translating advances in AI into scientific insights that may contribute to future treatments.